<DOC>
	<DOCNO>NCT01454011</DOCNO>
	<brief_summary>The study design answer follow question : 1 . Is difference composition HDL cholesterol subpopulation patient hypogonadism healthy control . 2 . What effect testosterone replacement therapy distribution HDL subgroup . 3 . Is difference effect two different testosteron replacement regiment</brief_summary>
	<brief_title>The Effect Testosterone Replacement High Density Lipoprotein Cholesterol Subgroups</brief_title>
	<detailed_description>This study two design : 1 . The case control design search difference HDL subgroups metabolic parameter healthy subject patient hypogonadism 2 . The follow-up study search effect two different testosterone replacement regiment .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Congenital hypogonadotrophic hypogonadism , Male sex Previous history androgen replacement , chronic disorder</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>hypogonadism</keyword>
	<keyword>testosterone</keyword>
	<keyword>HDL cholesterol subgroup</keyword>
	<keyword>hsCRP</keyword>
	<keyword>HOMA-IR</keyword>
</DOC>